Figure 3From: Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guidelinePercentage of patients without diabetes (DM-), with mild diabetes (DM+) and with severe diabetes (DM++) receiving aldosterone receptor blockade therapy. On the left panel, results are shown for patients with preserved renal function (GFR >60 ml/min), and on the right panel for patients with reduced renal function.Back to article page